Brief: Matinas Biopharma Holdings Inc Keith Kucinski Resigns As CFO Effective January 17, 2026
23/01/2026 22:33
Jan 23 (Reuters) - Matinas BioPharma Holdings Inc MTNB.A: MATINAS BIOPHARMA HOLDINGS INC - KEITH KUCINSKI RESIGNS AS CFO EFFECTIVE JANUARY 17, 2026 - SEC FILING MATINAS BIOPHARMA HOLDINGS INC - JEROME D. JABBOUR APPOINTED INTERIM CFO EFFECTIVE JANUARY 22, 2026 - SEC FILING Source text: [ID:n0001493152-26-003445] Further company coverage: MTNB.A ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Matinas BioPharma Holdings
See all newsBrief: GH Power Signs Multi-Year Hydrogen Offtake Agreement With Change Energy For Hamilton Facility Output
Brief: Gh Power And Tkms Continue To Explore Clean Energy Collaboration In Support Of Canada’S Future Patrol Submarine Project
Brief: Matinas Biopharma - Btig Terminates Sales Agreement With Matinas Biopharma Holdings, Effective Immediately On July 23, 2026 - SEC Filing
Brief: Matinas Biopharma Receives Notice Of Non-Compliance With NYSE American Continued Listing Standards And Acceptance Of Plan To Regain Compliance
Brief: Matinas Biopharma - May Offer Securities Up To $150 Million - SEC Filing